A feasibility, toxicity, and early response study of etoposide, ifosfamide, and vincristine for the treatment of children with rhabdomyosarcoma: A report from the intergroup rhabdomyosarcoma study (IRS) IV pilot study

Carola A.S. Arndt, Mariella Tefft, Edmund Gehan, James Anderson, Michelle Jenson, Michael Link, Sarah Donaldson, John Breneman, Eugene Wiener, Bruce Webber, Harold Maurer

Research output: Contribution to journalArticlepeer-review

44 Scopus citations

Fingerprint

Dive into the research topics of 'A feasibility, toxicity, and early response study of etoposide, ifosfamide, and vincristine for the treatment of children with rhabdomyosarcoma: A report from the intergroup rhabdomyosarcoma study (IRS) IV pilot study'. Together they form a unique fingerprint.

Medicine & Life Sciences